Analysis of acid-suppressive drug choice after PCI in patients with coronary heart diseases

Chinese Journal of New Drugs

Volumn 22, Issue 8, 2013, Pages

  Du, Yu ^a   Wang, Miao ^a   Pan, Jin Shui ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Acid suppressive drugs; Coronary heart disease; Percutaneous coronary interventions; Proton pump inhibitors; Reasonable drug use; Upper gastrointestinal bleeding

Indexed keywords

ANTITHROMBOCYTIC AGENT; FAMOTIDINE; HYDROTALCITE; PANTOPRAZOLE; RABEPRAZOLE;

ARTICLE; CLINICAL RESEARCH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL RECORD; PERCUTANEOUS CORONARY INTERVENTION; UPPER GASTROINTESTINAL BLEEDING;

EID: 84881308391     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. 2010, 8(2): 154-156.
2. LI X Q, ANDERSSON T B, AHLSTR M M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities [J]. Drug Metab Dispos, 2004, 32(8): 821-827.
3. TENTZERIS I, JARAI R, FARHAN S, et al. Impact of concomitant treatment with proton pump inhibitors and clopidogrel onclinical outcome in patients after coronary stent implantation [J]. Thromb Haemost, 2010, 104(6): 1211-1218.
4. SARAFOFF, SIBBING D, SONNTAG U, et al. Risk of drugeluting stent thrombosis in patientsreceiving proton pump inhibitors [J]. Thromb Haemost, 2010, 104(3): 626-632.
5. SIRISWANGVAT S, SANSANAYUDH N, NATHISUWAN S, et al. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel [J]. Circ J, 2010, 74(10): 2187-2192.
6. GILARD M, ARNAUD B, CORNILY J C, et al. Influence ofomeprazole on the antiplatelet action of clopidogrel associated with aspirin the randomized double-blind OCLA(Omeprazole CLopidogrel Aspirin) study [J]. J Am Coll Cardiol, 2008, 51(3): 256-2260.
7. SMALL D S, FARRID N A, PAYNE C D. Effects of theproton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel [J]. Clin Pharmacol, 2008, 48(4): 475-484.
8. SILLER-MATULA J M, SPIEL A O, LANG I M. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel [J]. Am Heart J, 2009, 157(1): 148.
9. JUURLINK D N, GOMES T, KO D T, et al. A populat ion-based study of the drug interacti on between proton pum pinhibitors and clop idogrel [J]. CMA J, 2009, 180(7): 713-718.
10. FURUTA T, IWAKI T, UMEMURA K. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes [J]. Br J Clin Pharmacol, 2010, 70(3): 383-392.